NASDAQ:SIBN SI-BONE (SIBN) Stock Price, News & Analysis $12.74 -0.24 (-1.85%) (As of 10/23/2024 ET) Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends About SI-BONE Stock (NASDAQ:SIBN) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get SI-BONE alerts:Sign Up Key Stats Today's Range$12.56▼$13.0950-Day Range$12.81▼$17.0152-Week Range$11.76▼$21.70Volume249,281 shsAverage Volume379,787 shsMarket Capitalization$531.13 millionP/E RatioN/ADividend YieldN/APrice Target$22.67Consensus RatingBuy Company OverviewSI-BONE, Inc., a medical device company, that operate to solve musculoskeletal disorders of the sacropelvic anatomy in the United States and internationally. It offers proprietary minimally invasive surgical implant system to address sacroiliac joint dysfunction and fusion, adult deformity and degeneration, and pelvic trauma; and implantable bone products. The company also provides iFuse-3D, a titanium implant that combines the triangular cross-section of the iFuse implant with the proprietary 3D-printed porous surface and fenestrated design; iFuse-TORQ, a set of 3D-printed threaded implants designed to treat pelvic trauma; and iFuse Bedrock Granite implant provides sacroiliac fusion and sacropelvic fixation as a foundational element for segmental spinal fusion. It markets its products primarily with a direct sales force, as well as through agents and resellers. SI-BONE, Inc. was incorporated in 2008 and is headquartered in Santa Clara, California.Read More… Watch this before it gets removed (Ad)If you missed it, my emergency election broadcast is now available - but will be removed soonClick here to watch it now. SI-BONE Stock Analysis - MarketRank™See Top Rated MarketRank™ Stocks75th Percentile Overall ScoreSIBN MarketRank™: SI-BONE scored higher than 75% of companies evaluated by MarketBeat, and ranked 264th out of 1,001 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion3.5 / 5Analyst RatingBuy Consensus RatingSI-BONE has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 6 buy ratings, no hold ratings, and no sell ratings.Amount of Analyst CoverageSI-BONE has only been the subject of 3 research reports in the past 90 days.Read more about SI-BONE's stock forecast and price target. Earnings and Valuation0.6 / 5Proj. Earnings GrowthGrowing Earnings GrowthEarnings for SI-BONE are expected to grow in the coming year, from ($0.89) to ($0.74) per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of SI-BONE is -12.61, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of SI-BONE is -12.61, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioSI-BONE has a P/B Ratio of 3.05. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.Read more about SI-BONE's valuation and earnings. Short Interest2.0 / 5Short Interest LevelBearish Percentage of Shares Shorted4.05% of the outstanding shares of SI-BONE have been sold short.Short Interest Ratio / Days to CoverSI-BONE has a short interest ratio ("days to cover") of 4.9.Change versus previous monthShort interest in SI-BONE has recently increased by 2.42%, indicating that investor sentiment is decreasing. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldSI-BONE does not currently pay a dividend.Dividend GrowthSI-BONE does not have a long track record of dividend growth. Sustainability and ESG3.3 / 5Environmental Score-1.44 Percentage of Shares Shorted4.05% of the outstanding shares of SI-BONE have been sold short.Short Interest Ratio / Days to CoverSI-BONE has a short interest ratio ("days to cover") of 4.9.Change versus previous monthShort interest in SI-BONE has recently increased by 2.42%, indicating that investor sentiment is decreasing. News and Social Media0.6 / 5News SentimentN/A News Coverage This WeekMarketBeat has tracked 1 news article for SI-BONE this week, compared to 3 articles on an average week.Search InterestOnly 1 people have searched for SIBN on MarketBeat in the last 30 days. This is a decrease of 0% compared to the previous 30 days.MarketBeat Follows1 people have added SI-BONE to their MarketBeat watchlist in the last 30 days. Company Ownership2.5 / 5Insider TradingSelling Shares Insider Buying vs. Insider SellingIn the past three months, SI-BONE insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $349,879.00 in company stock.Percentage Held by InsidersOnly 3.90% of the stock of SI-BONE is held by insiders.Percentage Held by Institutions98.11% of the stock of SI-BONE is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about SI-BONE's insider trading history. Receive SIBN Stock News and Ratings via Email Sign-up to receive the latest news and ratings for SI-BONE and its competitors with MarketBeat's FREE daily newsletter. Email Address SIBN Stock News HeadlinesAnthony J. Recupero Sells 3,305 Shares of SI-BONE, Inc. (NASDAQ:SIBN) StockOctober 7, 2024 | insidertrades.comSI-BONE To Report Third Quarter 2024 Financial Results on November 12, 2024October 22 at 4:09 PM | globenewswire.comWatch this before it gets removed If you missed it, my emergency election broadcast is now available - but will be removed soonOctober 24, 2024 | Porter & Company (Ad)Truist Financial Trims SI-BONE (NASDAQ:SIBN) Target Price to $16.00October 17, 2024 | americanbankingnews.comSI-BONE, Inc. Announces First-In-Patient Procedures with FDA Breakthrough Device for Pelvic Fracture FixationOctober 10, 2024 | globenewswire.comSI-BONE (NASDAQ:SIBN) Stock Quotes, Forecast and News SummaryOctober 7, 2024 | benzinga.comBuy Rating Justified: SI-Bone’s Growth Potential and Market Expansion OpportunitiesSeptember 7, 2024 | markets.businessinsider.comSIBN Sep 2024 17.500 callAugust 30, 2024 | ca.finance.yahoo.comSee More Headlines SIBN Stock Analysis - Frequently Asked Questions How have SIBN shares performed this year? SI-BONE's stock was trading at $20.99 at the start of the year. Since then, SIBN shares have decreased by 39.3% and is now trading at $12.74. View the best growth stocks for 2024 here. How were SI-BONE's earnings last quarter? SI-BONE, Inc. (NASDAQ:SIBN) announced its quarterly earnings results on Monday, August, 5th. The company reported ($0.22) EPS for the quarter, beating the consensus estimate of ($0.26) by $0.04. The company earned $39.97 million during the quarter, compared to analyst estimates of $38.95 million. SI-BONE had a negative trailing twelve-month return on equity of 24.27% and a negative net margin of 27.10%. Does SI-BONE have any subsidiaries? SI-BONE subsidiaries include these companies: SI-BONE Deutschland GmbH, SI-BONE S.R.L., and SI-BONE UK LTD. When did SI-BONE IPO? SI-BONE (SIBN) raised $84 million in an initial public offering (IPO) on Wednesday, October 17th 2018. The company issued 6,000,000 shares at a price of $13.00-$15.00 per share. Morgan Stanley and BofA Merrill Lynch acted as the underwriters for the IPO and Canaccord Genuity and JMP Securities were co-managers. Who are SI-BONE's major shareholders? SI-BONE's top institutional investors include Essex Investment Management Co. LLC (0.41%), Diversified Trust Co (0.07%) and SG Americas Securities LLC (0.06%). Insiders that own company stock include Laura Francis, Anthony J Recupero, Anshul Maheshwari, Michael A Pisetsky, John Gordon Freund, Timothy E Davis Jr and Mika Nishimura. View institutional ownership trends. How do I buy shares of SI-BONE? Shares of SIBN stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. What other stocks do shareholders of SI-BONE own? Based on aggregate information from My MarketBeat watchlists, some other companies that SI-BONE investors own include American Water Works (AWK), Voyager Therapeutics (VYGR), Humana (HUM), Waste Connections (WCN), The RMR Group (RMR), AUO (AUOTY) and DiamondRock Hospitality (DRH). Company Calendar Last Earnings8/05/2024Today10/23/2024Next Earnings (Confirmed)11/12/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Surgical & medical instruments Sub-IndustryMedical Equipment Current SymbolNASDAQ:SIBN CUSIPN/A CIK1459839 Webwww.si-bone.com Phone(408) 207-0700FaxN/AEmployees350Year Founded2008Price Target and Rating Average Stock Price Target$22.67 High Stock Price Target$32.00 Low Stock Price Target$16.00 Potential Upside/Downside+77.9%Consensus RatingBuy Rating Score (0-4)3.00 Research Coverage6 Analysts Profitability EPS (Most Recent Fiscal Year)($1.01) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-43,340,000.00 Net Margins-27.10% Pretax Margin-27.10% Return on Equity-24.27% Return on Assets-17.98% Debt Debt-to-Equity Ratio0.22 Current Ratio9.17 Quick Ratio8.12 Sales & Book Value Annual Sales$138.89 million Price / Sales3.82 Cash FlowN/A Price / Cash FlowN/A Book Value$4.18 per share Price / Book3.05Miscellaneous Outstanding Shares41,690,000Free Float40,068,000Market Cap$531.13 million OptionableOptionable Beta1.22 Social Links Metaverse Stocks And Why You Can't Ignore ThemThinking about investing in Meta, Roblox, or Unity? Click the link to learn what streetwise investors need to know about the metaverse and public markets before making an investment.Get This Free Report This page (NASDAQ:SIBN) was last updated on 10/24/2024 by MarketBeat.com Staff From Our Partnerstop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)AI was by far the biggest tech investing trend right now. But Ross Givens says the #1 artificial intelligen...Traders Agency | SponsoredProtect Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredMusk warns humanity: “Obsolete”The 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredWatch this before it gets removed If you missed it, my emergency election broadcast is now available - but will be removed soonPorter & Company | Sponsored #1 Pre-IPO Opportunity For 2024 [Take Action Now!]According to James, the largest IPO in history could kick off in a matter of weeks. I’m talking about Starl...Paradigm Press | SponsoredMarket "Famine" ComingMarket Wizard Larry Benedict accurately predicted that all indexes would be negative in 2022... He predicte...Opportunistic Trader | SponsoredGoldman Sachs’ AI warningAfter warning of last year's historic bank run, weeks in advance... Legendary stock-picker Marc Chaikin jus...Chaikin Analytics | SponsoredHow Will You Survive A Post Election Retirement Heist?The clock is ticking, and your life savings are in an extremely vulnerable position. We are a few days away...American Hartford Gold Group | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding SI-BONE, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share SI-BONE With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.